YPeg-IFNα-2a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YPeg-IFNα-2a, covering 2011-04-04 to 2011-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C [Phase 2, Phase 3]